Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permixon versus tamsulosin for inflammation biomarkers in benign prostatic hyperplasia
2011-005307-33Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saw palmetto fruit extract, tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Pierre Fabre Laboratories. Started Feb 2012; status: completed.
02
Drugs
saw palmetto fruit extracttamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2011-005307-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005307-33.